REFERENCES
- CancerStats Incidence 2008-UK. Accessed 1 June 2012 from: http://info.cancerresearchuk.org/prod_consump/groups/cr_common/@nre/@sta/documents/generalcontent/cr_072111.pdf
- American Cancer Society.Cancer facts and figures 2011. Accessed 1 June 2012 from: http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-029771.pdf
- Yearbook of Chinese health statistics, 2010. Accessed 1 June 2012 from: http://www.moh.gov.cn/publicfiles/business/htmlfiles/zwgkzt/ptjnj/year2010/index 2010.html.">
- Yang PS, Yang YL, Liu CL, . A case-control study of breast cancer in Taiwan – a low incidence area. Br J Cancer 1997;75:752–6.
- Ng EH, Gao F, Ji CY, . Risk factors for breast carcinoma in Singaporean Chinese women: The role of central obesity. Cancer 1997;80:725–31.
- United Nations.World contraceptive use 2011. Accessed 5 June 2012 from: www.un.org/esa/population/publications/contraceptive2011/wallchart_front.pdf
- Stroup DF, Berlin JA, Morton SC, . Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008–12.
- Greenland S, Longecker MP. Methods for trend estimation from summarized dose-response data, with application to meta-analysis. Am J Epidemiol 1992;135: 1301–9.
- Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088–101.
- Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629–34.
- Kawai M, Minami Y, Kuriyama S, . Reproductive factors, exogenous female hormone use and breast cancer risk in Japanese: the Miyagi Cohort Study. Cancer Causes Control 2010;21:135–45.
- Lee SY, Kim MY, Kim SW, . Effect of lifetime lactation on breast cancer risk: Korean women's cohort study. Int J Cancer 2003;105:390–3.
- Dumeaux V, Alsaker E, Lund E. Breast cancer and specific types of oral contraceptives: A large Norwegian cohort study. Int J Cancer 2003;105:844–50.
- Wu MH, Chou YC, Yu JC, . Hormonal and body-size factors in relation to breast cancer risk: A prospective study of 11,889 women in a low-incidence area. Ann Epidemiol 2006;16:223–9.
- Hankinson SE, Colditz GA, Manson JE, . A prospective study of oral contraceptive use and risk of breast cancer (Nurses’ Health Study, United States). Cancer Causes Control 1997;8:65–72.
- Mills PK, Beeson WL, Phillips RL, Fraser GE. Prospective study of exogenous hormone use and breast cancer in Seventh-day Adventists. Cancer 1989;64:592–7.
- Schuurman AG, van den Brandt PA, Goldbohm RA. Exogenous hormone use and the risk of postmenopausal breast cancer: Results from the Netherlands Cohort Study. Cancer Causes Control 1995;6:416–24.
- Kumle M, Weiderpass E, Braaten T, . Use of oral contraceptives and breast cancer risk: The Norwegian-Swedish Women's Lifestyle and Health Cohort Study. Cancer Epidemiol Biomarkers Prev 2002;11:1375–81.
- Hunter DJ, Colditz GA, Handkinson SE, . Oral contraceptive use and breast cancer: A prospective study of young women. Cancer Epidemiol Biomarkers Prev 2010;19:2496–502.
- Dorjgochoo T, Shu XO, Li HL, . Use of oral contraceptives, intrauterine devices and tubal sterilization and cancer risk in a large prospective study, from 1996 to2006.Int J Cancer2009;124:2442–9.
- Dumeaux V, Fournier A, Lund E, Clavel-Chapelon F. Previous oral contraceptive use and breast cancer risk according to hormone replacement therapy use among postmenopausal women. Cancer Causes Control 2005;16:537–44.
- Hannaford PC, Slevaraj S, Elliott AM, . Cancer risk among users of oral contraceptives: Cohort data from the Royal College of General Practitioner's oral contraception study. BMJ 2007;335:651–4.
- Van Hoften C, Burger H, Peeters PH, . Long-term oral contraceptive use increases breast cancer risk in women over 55 years of age: The DOM cohort. Int J Cancer 2000;87:591–4.
- Beral V, Hermon C, Kay C, . Mortality associated with oral contraceptive use: 25 year follow up of cohort of 46000 women from Royal College of General Practitioners’ oral contraception study. BMJ 1999;318: 96–100.
- Vessey M, Yeates D, Flynn S. Factors affecting mortality in a large cohort study with special reference to oral contraceptive use. Contraception 2010;82:221–9.
- Wingo PA, Austin H, Marchbank PA, . Oral contraceptives and the risk of death from breast cancer. Obstet Gynecol 2007;110:793–800.
- Brohet RM, Goldgar DE, Easton DF, . Oral contraceptives and breast cancer risk in the international BRCA1/2 carrier cohort study: A report from EMBRSCE, GENEPSO, GEO-HEBON, and the IBCCS collaboration group. J Clin Oncol 2007;25: 3831–6.
- Grabrick DM, Hartmann LC, Cerhan JR, . Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer. JAMA 2000; 284:1791–8.
- Silvera SA, Miller AB, Rohan TE. Oral contraceptive use and risk of breast cancer among women with a family history of breast cancer: A prospective cohort study. Cancer Causes Control 2005;16:1059–63.
- Rosenberg L, Boggs DA, Wise LA, . Oral contraceptive use and estrogen/progesterone receptor-negative breast cancer among African American women. Cancer Epidemiol Biomarkers Prev 2010;19:2073–9.
- Lawson JS, Field AS, Champion S, . Low oestrogen receptor alpha expression in normal breast tissue underlies low breast cancer incidence in Japan. Lancet 1999;354:1787–8.
- Collaborative Group on Hormonal Factors in Breast Cancer.Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53297 women with breast cancer and 100239 women without breast cancer from 54 epidemiologic studies. Lancet 1996;347:1713–27.
- Kahlenborn C, Modugno F, Potter DM, . Oral contraceptive use as a risk factor for premenopausal breast cancer: A meta-analysis. Mayo Clin Proc 2006;81: 1290–302.
- Isaksson E, von Schoultz E, Odlind V, . Effects of oral contraceptives on breast epithelial proliferation. Breast Cancer Res Treat 2001;65:163–9.
- Garcia y Narvaiza D, Navarrete MA, Falzoni R, . Effect of combined oral contraceptives on breast epithelial proliferation in young women. Breast J 2008;14: 450–5.
- Selby C. Sex hormone binding globulin: Origin, function and clinical significance. Ann Clin Biochem 1990;27:532–41.
- Lagerlund M, Sparen P, Thurfjell E, . Predictors of non-attendance in a population-based mammography screening programme; socio-demographic factors and aspects of health behaviour. Eur J Cancer Prev 2000;9: 25–33.
- Manzoli L, De Vito C, Marzuillo C, . Oral contraceptives and venous thromboembolism: A systematic review and meta-analysis. Drug Saf 2012;35: 191–205.
- Baillargeon JP, McClish DK, Essah PA, . Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: A meta-analysis. J Clin Endocrinol Metab 2005;90 :3863–70.
- Collaboration Group on Epidemiological Studies of Ovarian Cancer, Beral V, Doll R, . Ovarian cancer and oral contraceptives: Collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls. Lancet 2008;371:303–14.
- Burkman R, Schlesselman JJ, Zieman M. Safety concerns and health benefits associated with oral contraception. Am J Obstet Gynecol 2004;190:S5–22.